BioServe will use its Global Repository—which comprises more than 600,000 human DNA, tissue and serum samples linked to detailed clinical and demographic information—to assist the Specialized Clinical Center of Research (SCCOR) conduct a novel study aimed at identifying the genetic cause of thoracic aortic disease. The repository was the key asset of Genomics Collaborative which was recently acquired by BioServe (DDN, June 2007).
Frontage Laboratories, a five-year-old CRO that provides bioanalytical, preclinical and drug development services, announced that it has acquired a “significant equity interest” in Advanced Biomedical Research Inc., a Princeton, N.J.-based CRO which operates clinical trials internationally.
Evotec AG launched its new Innovation Centre for Fragment Based Drug Discovery (FBDD) in late May. The center draws on internal capabilities and outside scientists, and is the first of a series of new business units aimed at providing enhanced access to innovative discovery techniques.
Ambrx has high hopes that a recently announced collaboration with Merck Serono to develop and commercialize Ambrx’s long-acting growth hormone products will mean much more than just milestone payments and royalties.
Genedata, a leading computational solutions provider, recently initiated what it calls a “major research informatics solution deal” with the global biopharmaceutical company UCB, a Brussels, Belgium-based biopharmaceutical company focused on products in the areas of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders and oncology.
Thermo Fisher Scientific Inc. has entered a new strategic partnership with Megaware Inc., a life science technology organization with offices in Westborough, Mass., and Mumbai, India, to deliver a bioanalysis and equivalence solution and joint support services for pharmaceutical, biotech and contract research organizations (CROs).
Looking to help drive sales of its high-density microarrays and to potentially provide its customers with significant savings in time and money in their whole-genome association studies, Illumina Inc. announced last month iControlDB, a company-hosted genotyping repository that contains data from nearly 10,000 control samples.
A group of major universities recently announced that they plan to take a coordinated approach in the development and application of computational sciences and intend to focus their efforts on the rapidly emerging field of computational biology.
Bayer HealthCare Pharmaceuticals Inc. and Onyx Pharmaceuticals Inc. recently announced that a supplemental New Drug Application (sNDA) for Nexavar (sorafenib) tablets has been submitted to the FDA for the treatment of patients with hepatocellular carcinoma (HCC), the most common form of liver cancer.
BASEL, Switzerland—Roche recently announced two new technology transfers with local manufacturing companies in Africa: Addis Pharmaceutical Factory in Ethiopia and Varichem Pharmaceuticals in Zimbabwe.